Maria Palasis, Ph.D.
Lyra Therapeutics, Inc.
Maria Palasis, Ph.D., is the CEO of Lyra Therapeutics, Inc., a biopharmaceutical company focused on developing innovative drug delivery solutions for chronic respiratory conditions. Dr. Palasis’s leadership is characterized by a commitment to advancing novel therapeutic approaches and enhancing patient outcomes through cutting-edge technology. With extensive experience in biotechnology and drug development, she has been instrumental in guiding Lyra Therapeutics through pivotal stages of research and clinical trials. Her strategic vision includes leveraging advanced delivery systems to address unmet medical needs in respiratory care. Under her guidance, the company continues to progress in developing breakthrough therapies that improve the quality of life for patients with chronic conditions.